Literature DB >> 16227139

Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.

Juan F Delgado1, Esther Conde, Violeta Sánchez, Fernando López-Ríos, Miguel A Gómez-Sánchez, Pilar Escribano, Teresa Sotelo, Agustín Gómez de la Cámara, José Cortina, Carlos S de la Calzada.   

Abstract

UNLABELLED: Pulmonary hypertension (PHT) associated with chronic heart failure (CHF) is a risk factor of right ventricular failure after heart transplantation (HT). Our aim was to study pulmonary vascular changes in patients with CHF and to assess any correlation with haemodynamic data.
METHODS: We studied 17 HT recipients with preoperative CHF who died shortly after HT. Preoperative haemodynamic information was obtained immediately before HT. Vascular lesions in muscular arteries were assessed by linear morphometry. Haemodynamic data were correlated with the morphologic changes.
RESULTS: Mean transpulmonary gradient (TPG) was 8.9+/-4.5 mm Hg and pulmonary vascular resistance (PVR) was 2.25+/-1.34 Wu. According to the threshold for at-risk PHT (TPG>12 mm Hg or PVR>2.5 Wu), six patients had at-risk PHT. Medial thickness was 23.82+/-7.23% in patients with at-risk PHT and 17.16+/-3.24% in patients without at-risk PHT (p=0.018).
CONCLUSIONS: Medial hypertrophy of muscular pulmonary arteries is more common and severe than expected in patients with CHF, even in patients without at-risk PHT. This structural change could explain why PHT, even in range of values not excluding HT, is a risk factor for right ventricular failure after HT and influences post-HT haemodynamic behaviour.

Entities:  

Mesh:

Year:  2005        PMID: 16227139     DOI: 10.1016/j.ejheart.2004.10.021

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  61 in total

1.  Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosis.

Authors:  Dimitry Schewel; Jury Schewel; Julia Martin; Lisa Voigtländer; Christian Frerker; Peter Wohlmuth; Thomas Thielsen; Karl-Heinz Kuck; Ulrich Schäfer
Journal:  Clin Res Cardiol       Date:  2014-11-04       Impact factor: 5.460

2.  Iron lung? New ideas about hypoxic pulmonary vasoconstriction.

Authors:  Michael J Joyner; Bruce D Johnson
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

3.  ECG-gated computed tomography to assess pulmonary capillary wedge pressure in pulmonary hypertension.

Authors:  Nancy Sauvage; Emilie Reymond; Adrien Jankowski; Marion Prieur; Christophe Pison; Hélène Bouvaist; Gilbert R Ferretti
Journal:  Eur Radiol       Date:  2013-06-09       Impact factor: 5.315

Review 4.  Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure.

Authors:  Matthias Dupont; W H Wilson Tang
Journal:  J Card Fail       Date:  2013-09-05       Impact factor: 5.712

Review 5.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

6.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Authors:  Barry A Borlaug; Masaru Obokata
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

7.  Approach to patients with heart failure and pulmonary hypertension.

Authors:  Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

8.  Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rebecca R Vanderpool; Melissa Saul; Mehdi Nouraie; Mark T Gladwin; Marc A Simon
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

9.  Arterial-ventricular and interventricular interaction in isolated post-capillary and combined pulmonary hypertension in severe mitral stenosis.

Authors:  Ashwin Venkateshvaran; Srikanth Sola; Satish Chandra Govind; Pravat Kumar Dash; Sagar Vyavahare; Lars H Lund; Bé la Merkely; Anikó Ilona Nagy; Aristomenis Manouras
Journal:  Eur J Appl Physiol       Date:  2016-05-19       Impact factor: 3.078

10.  Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation.

Authors:  Babak Daftari; Juan Carlos Alejos; Gregory Perens
Journal:  J Transplant       Date:  2010-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.